Spots Global Cancer Trial Database for ki67
Every month we try and update this database with for ki67 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer | NCT01965522 | Early Stage Bre... | Melatonin Vitamin D Placebo (melato... Placebo (vitami... | 18 Years - | Juravinski Cancer Center | |
| Usefulness of Ki67 Index in Hormone Receptor-positive Breast Cancer | NCT01273415 | Breast Cancer | 20 Years - 85 Years | Samsung Medical Center | ||
| Targeting the Hippo Transducer TAZ in Breast Cancer With Statins | NCT02416427 | Breast Neoplasm... | Atorvastatin | 18 Years - 75 Years | Regina Elena Cancer Institute | |
| Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia | NCT04753229 | Neuroendocrine ... | 18 Years - | Institut Paoli-Calmettes | ||
| Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer | NCT01965522 | Early Stage Bre... | Melatonin Vitamin D Placebo (melato... Placebo (vitami... | 18 Years - | Juravinski Cancer Center | |
| Anti-proliferative Effects of Vitamin D and Melatonin in Breast Cancer | NCT01965522 | Early Stage Bre... | Melatonin Vitamin D Placebo (melato... Placebo (vitami... | 18 Years - | Juravinski Cancer Center | |
| Biological and Clinical Effects of Palbociclib With Ovarian Suppression and Letrozole in the Neoadjuvant Treatment of Breast Cancer | NCT03628066 | Breast Cancer | Letrozole Palbociclib Goserelin Oncotype DX Bre... | 18 Years - | NSABP Foundation Inc | |
| Paclitaxel Plus Pembrolizumab vs. Paclitaxel Weekly in ER+ Luminal B Metastatic Breast Cancer | NCT03841747 | Breast Cancer | Pembrolizumab Paclitaxel | 18 Years - | Queen Mary University of London | |
| Ki67 Proliferation Index of Pancreatic Neuroendocrine Neoplasia | NCT04753229 | Neuroendocrine ... | 18 Years - | Institut Paoli-Calmettes | ||
| Tailoring NEOadjuvant Therapy in Hormone Receptor Positive, HER2 Negative, Luminal Breast Cancer. | NCT03283384 | Breast Neoplasm... | Letrozole Chemotherapy Ribociclib plus... | 18 Years - | Borstkanker Onderzoek Groep | |
| Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | NCT00816244 | Breast Cancer Postmenopausal | Atorvastatin | 18 Years - | Lund University Hospital | |
| EDICT - Exercise inDuced Changes In Colorectal Cancer Tissues | NCT02056691 | Colorectal Canc... | Exercise progra... Muscle biopsy | 18 Years - | The Royal Bournemouth Hospital | |
| INVINCIBLE TRIAL: Intratumoral INT230-6 in Breast Cancer | NCT04781725 | Breast Cancer | INT230-6 Saline injectio... | - | Ottawa Hospital Research Institute | |
| Study of Statin as Neo-Adjuvant Therapy in Postmenopausal Breast Cancer | NCT00816244 | Breast Cancer Postmenopausal | Atorvastatin | 18 Years - | Lund University Hospital | |
| Targeting the Hippo Transducer TAZ in Breast Cancer With Statins | NCT02416427 | Breast Neoplasm... | Atorvastatin | 18 Years - 75 Years | Regina Elena Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
